SCROLL NEWS / DISCOVERY

Search headlines

Find the stories shaping the conversation.

Search mode
Refine results
Active filters Keyword All time

Results for " aly " 5,326 found 🔀 AI-powered Shuffle

Trump likely to ‘lose’ on birthright citizenship case, political analyst says

Fox News senior political analyst Juan Williams discusses the Supreme Court set to issue a ruling on birthright citizenship on ‘Special Report.’

foxnews.com logo
Jun 25 • 8:09 PM EDT • Politics • foxnews.com
😐 Neutral (0%)
Caitlin Clark made the WNBA bigger. It’s still playing small

The league’s paltry one-game suspension of Alyssa Thomas after her fist to Caitlin Clark's throat barely begins to address the problem.

usatoday.com logo
Jun 25 • 6:58 PM EDT • Sports • usatoday.com
This autism therapy is covered by many insurers. Why does the military’s plan restrict it?

Logan Cabiao started applied behavior analysis therapy for autism when he was 2. Several years later, TRICARE, the military’s healthcare program, imposed major coverage restrictions.

nbcnews.com logo
Jun 25 • 6:06 PM EDT • Health • nbcnews.com
High-Signal Publisher
Moore links Maryland primary to Mamdani-backed wins; analysts disagree

Gov. Wes Moore says Maryland’s primary election showed voters rejected the status quo, but political analysts say the results reflect a more complicated picture.

baltimoresun.com logo
Jun 25 • 6:00 PM EDT • Politics • baltimoresun.com
Making Our Own Luck

We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.

goodscience.substack.com logo
Jun 25 • 4:48 PM EDT • Science • goodscience.substack.com
Deep dive
😐 Neutral (10%)
wow
42%
ahah
33%
love
25%
Merck KGaA to Acquire Bio-Techne for $11.3B, Expanding Life Science Tools Presence

Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne for approximately $11.3 billion, the companies said today, in a deal designed to position the buyer as more of a leader across the life science value chain by expanding its presence in high-growth, next-generation life-sci markets with Bio-Techne’s tools, analytical technologies, and consumables.

genengnews.com logo
Jun 25 • 3:12 PM EDT • Science • genengnews.com
State health officials investigate Novi death, illnesses after dialysis

Police say no evidence of foul play in death, sicknesses following dialysis at DaVita.

freep.com logo
Jun 25 • 2:31 PM EDT • Health • freep.com
😐 Neutral (0%)
ahah
40%
love
40%
angry
20%
Europe heatwave breaks records as UN agencies ramp up health warnings

As a record-breaking heatwave grips large parts of Europe, the World Meteorological Organization (WMO), national weather services and partners are mobilising heat-health action plans for millions of people facing dangerous temperatures.

news.un.org logo
Jun 25 • 1:05 PM EDT • Health • news.un.org
CMS projects national health spending grew to $5.7 trillion in 2025

National health spending is projected to have reached $5.7 trillion in 2025, up 7.3% from 2024, according to an analysis by the Centers for Medicare & Medicaid Services published yesterday by Health Affairs. It marks the third consecutive year of growth greater than 7%. CMS projects growth to continue in 2026 due to continued demand for high-cost retail prescription drugs, mostly from individuals with Medicare and private insurance.

aha.org logo
Jun 25 • 10:44 AM EDT • Health • aha.org
How Elifin is reshaping the commercial real estate playbook

Elifin is leveraging a decade's worth of proprietary commercial real estate data as well as artificial intelligence to reshape how properties are marketed, analyzed and sold. The Baton Rouge-based … Already an INSIDER? Sign in. Already an INSIDER? Sign in

businessreport.com logo
Jun 25 • 10:24 AM EDT • Business • businessreport.com
Grand Theft Auto VI pre-orders open, but don’t expect a physical copy

The blockbuster launch is expected to dwarf the box office takings of the year’s biggest movies with one industry analyst predicting it could make $1bn within an hour

theguardian.com logo
Jun 25 • 10:17 AM EDT • Technology • theguardian.com
Scientists Analyzed the Bones of ‘Skeleton Lake.’ What They Found Made No Sense.

Roopkund Lake sits in a frozen pocket of the Himalayas where hundreds of people died across a millennium. So why did researchers find bones from the island of Crete there?

popularmechanics.com logo
Jun 25 • 9:30 AM EDT • Science • popularmechanics.com
Living with a cat: the mental health impact scientists are only now discovering - Futura-Sciences

A Surprising Connection Between Cats and Schizophrenia? An Australian study has revealed an unexpected link between cat ownership and the risk of developing schizophrenia. Researchers analyzed 17 studies conducted over 44 years, spanning 11 different countries. Their conclusion? Living with a cat could actually double your risk of developing schizophrenia-related...

futura-sciences.com logo
Jun 25 • 8:00 AM EDT • Science • futura-sciences.com
How should European scientists respond to the US AI kill switch?

Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.

sciencebusiness.net logo
Jun 25 • 8:00 AM EDT • Science • sciencebusiness.net
Hims' obesity drug business may get boost as employers drop coverage

Telehealth provider Hims and Hers Health may get a boost next year from employers dropping coverage of weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo ​to rein in costs, investors and analysts say.

reuters.com logo
Jun 25 • 6:04 AM EDT • Business • reuters.com
Bologna open talks for Rangers' Raskin

Rangers midfielder attracts interest from Italy and England and Scotland goalkeeper could land move to Premier League giants...

sports.yahoo.com logo
Jun 25 • 3:17 AM EDT • Sports • sports.yahoo.com
Deep dive
😐 Neutral (2%)
wow
100%
2026 NBA Draft grades, second-round pick-by-pick analysis
sports.yahoo.com logo
Jun 24 • 8:22 PM EDT • Sports • sports.yahoo.com
5th European Conference on Xylella fastidiosa: science drives progress towards sustainable management

The 5th European Conference on Xylella fastidiosa concluded today in Mola di Bari, Italy, confirming that research on one of the world's most damaging plant pathogens has reached a new level of maturity.

efsa.europa.eu logo
Jun 24 • 8:00 PM EDT • Science • efsa.europa.eu
2026 NBA Draft grades: Updating pick-by-pick analysis from AJ Dybantsa, Cameron Boozer through Round 2

Adam Finkelstein has the breakdown of each pick in one of the best drafts in recent memory

cbssports.com logo
Jun 24 • 6:33 PM EDT • Sports • cbssports.com
Is This How Nike Is Shaking Up Its China Business?

BNP analyst Laurent Vasilescu considers the risk for Nike if a media report is accurate about a plan to change in distribution in China.

wwd.com logo
Jun 24 • 3:02 PM EDT • Business • wwd.com
Health insurers propose high rate hikes for 2027 Minnesota plans

To find out why and how much it'll burden customers, policy analyst Matt McGough with KFF Health News joined Morning Edition Wednesday.

mprnews.org logo
Jun 24 • 2:46 PM EDT • Health • mprnews.org
😐 Neutral (4%)
ahah
67%
angry
33%
Bosnia and Herzegovina vs. Qatar Live Updates, Score: Who Will Grab 3rd Place In Group B?

Follow Bosnia and Herzegovina vs. Qatar live at the 2026 FIFA World Cup. Real-time score updates, key plays, and match analysis as it happens.

foxsports.com logo
Jun 24 • 2:26 PM EDT • Sports • foxsports.com
Online violence against women in politics: what shapes political party responses to technology-facilitated gender-based violence?

Political parties have a primary role to play in tackling online violence against women and gender diverse politicians. While the prevalence and impact of TFGBV, such as coordinated disinformation campaigns, deepfake image-based sexual abuse or trolling are well documented, many parties are still building their knowledge on how to respond effectively and have not put in place internal practices and policies that respond to the rapidly evolving, poorly regulated digital ecosystem. About the ReportIn order to promote and protect fair and democratic participation in politics, this ALIGN Report explores what political parties are doing in response to TFGBV and what factors shape their action. The findings, based on existing literature and interviews with gender and politics professionals, indicate there are three sets of factors which donors, civil society and practitioners should consider when designing action to support political parties to respond to TFGBV internally. These are: (1) gender norms; (2) socio-political environment; and (3) internal party factors.Key messagesUnequal gender norms are ubiquitous across politics, shaping expectations of leaders to be strong and assertive, and practices of political parties to uphold masculinist values and sustain cultures of silence. These often lead to weak response to TFGBV against women politicians.The socio-political context can incentivise or disincentivise action, depending on the salience of gender issues, which are increasingly weaponised. Electoral competitiveness, domestic laws (i.e. quota requirements), and even the political system or global normative frameworks influence political will to act.Internal party factors that shape responses will vary across countries and contexts, but include: structures to enforce codes of conduct, policies and reporting mechanisms on (TF)GBV, political ideology, extent of centralisation of leadership, and crucially the meaningful participation of women in decision-making positions, not least through internal women’s wings.Party responses can be seen as a spectrum, with actions falling between active discouragement to address TFGBV to commitment to transform unequal norms and practices within the party.About the ToolkitTogether with the report, this ALIGN toolkit offers gender professionals and others working on democratic strengthening a set of guiding questions and reflection prompts to identify which responses could be most effective and suitable in different contexts. These actions can complement other solutions to TFGBV, such as regulations promoting safety by design. The assessment spans a broad range of factors including: (1) different manifestations of gender norms, (2) the socio-political environment and (3) internal party structures.Key messagesPolitical parties are duty-bound to take action internally to respond to the significant threats posed to women members and candidates, including from their own party colleagues, affiliates and political peers.Existing party approaches to TFGBV can be assessed along a spectrum which ranges from active discouragement and passive acceptance to minimal response and transformative change.To generate effective and context-appropriate solutions to TFGBV, it is important to consider how gender norms shape leadership expectations and internal party practices, while also analysing the impact of the socio-political environment. While actions to support women to stay safe online are very common, codes of conduct and measures to strengthen women’s voice and power in the parties are proposed as most transformative solutions.

odi.org logo
Jun 24 • 2:08 PM EDT • Politics • odi.org
This health data provider could benefit as AI reshapes drug research

Harvey Stober, senior equity analyst and correspondent at CNBC, explains why this healthcare company could benefit from artificial intelligence reshaping the drug industry thanks to its treasure trove of data.

cnbc.com logo
Jun 24 • 1:38 PM EDT • Health • cnbc.com
Cityblock in talks to buy fellow General Catalyst-backed startup Homeward Health

Cityblock Health in talks to acquire General Catalyst-backed rural care startup Homeward, expanding into Medicare Advantage, source says.

endpoints.news logo
Jun 24 • 1:20 PM EDT • Health • endpoints.news
New DNA study of Neanderthals bolsters suspicions of human-driven extinction

Analysis of 27 genomes reveals more diverse, better-connected populations and challenges the idea that genetic decline caused their disappearance

english.elpais.com logo
Jun 24 • 1:01 PM EDT • Science • english.elpais.com
UK, Italy and France issue health warnings during European heat wave
cbsnews.com logo
Jun 24 • 11:11 AM EDT • Health • cbsnews.com
High-Signal Publisher
Why 2 pitches from Seattle Mariners starters jump out

Logan Gilbert is riding one pitch to success, while Emerson Hancock is struggling with one of his own, Seattle Mariners analyst Ryan Rowland-Smith explains.

sports.mynorthwest.com logo
Jun 24 • 10:43 AM EDT • Sports • sports.mynorthwest.com
Walmart buying Vibe.co stirs big buzz at Cannes Lions: analysis

Walmart scored the deal everyone's talking about at Cannes Lions this year. Buying Vibe.co signals its intent to rival Meta, Google, and Amazon.

businessinsider.com logo
Jun 24 • 10:37 AM EDT • Business • businessinsider.com
This startup is using AI to close gaps in women’s healthcare

Xella Health’s precision health platform combines biomarker testing, clinical guidance, and AI analysis to help women get earlier answers about hard-to-diagnose conditions.

fastcompany.com logo
Jun 24 • 9:00 AM EDT • Health • fastcompany.com
Marco Palestra to Chelsea: Why Atalanta wing-back's dribbling and running power makes him a fit for the Premier League
skysports.com logo
Jun 24 • 8:34 AM EDT • Sports • skysports.com
Why South Africa’s leopards shrank to half their normal size

A hidden population of South African leopards has revealed a remarkable evolutionary story. Researchers analyzing entire leopard genomes discovered that the Cape Floristic Region’s leopards are not only much smaller than most African leopards, but also genetically distinct after being isolated for roughly 20,000 years. Surprisingly, despite their small population, they have retained much of their genetic diversity.

sciencedaily.com logo
Jun 24 • 8:00 AM EDT • Science • sciencedaily.com
CBS Sports ranks Falcons' 2026 offseason among worst in NFL

CBS Sports analyst ranks Falcons 2026 offseason fifth-worst in the NFL

sports.yahoo.com logo
Jun 24 • 6:01 AM EDT • Sports • sports.yahoo.com
The AI coding boom is creating workplace paralysis

New AI tools are released near-constantly. Some developers are invigorated, while others feel overwhelmed just trying to keep up.

businessinsider.com logo
Jun 24 • 5:55 AM EDT • Business • businessinsider.com
Da’Realyst Clark Named Athlon Sports Preseason All-American

KENT, Ohio – Kent State University return specialist Da'Realyst Clark has been named to the Athlon Sports 2026 Preseason All-America First Team as a kick ret...

kentstatesports.com logo
Jun 24 • 5:53 AM EDT • Sports • kentstatesports.com
Analysis | AI interests win, and lose, in one New York district

Democratic Assembly member Micah Lasher defeated fellow assemblyman Alex Bores in a race that became a proxy for how AI should be regulated.

washingtonpost.com logo
Jun 24 • 5:43 AM EDT • Politics • washingtonpost.com
Dave And Buster's Entertainment (PLAY) Stock Sees Fair Value Cut After Q1 Analyst Revisions

The fair value estimate for Dave & Buster's Entertainment has been revised from US$18.88 to US$17.00, bringing the price target closer to updated assumptions on comparable sales and earnings. Analysts link this adjustment to a balance of cautious near term expectations after Q1 and ongoing optimism that longer term changes in the business could still support the story if execution improves. Read on to see how this evolving narrative might shape how you track Dave & Buster's Entertainment from...

finance.yahoo.com logo
Jun 24 • 5:15 AM EDT • Entertainment • finance.yahoo.com
Analyst breaks down road map for Titans' preseason joint practices

The Tennessee Titans have scheduled three joint practices to prepare for the 2026 season under new leadership.

sports.yahoo.com logo
Jun 24 • 5:09 AM EDT • Sports • sports.yahoo.com
Deep dive
😐 Neutral (18%)
wow
45%
ahah
33%
love
22%
Here are Hogsett’s top campaign donors. Many do business with the city

A first-time analysis of Hogsett’s campaign fundraising shows it's largely driven by law firms, engineering companies and other powerbrokers.

indystar.com logo
Jun 24 • 5:02 AM EDT • Business • indystar.com
Oklahoma ACA insurer Mending to end health plans after this year

A health policy analyst says the move comes amid a broader trend of insurer exits as several federal policy changes fuel declining enrollment.

kosu.org logo
Jun 24 • 5:00 AM EDT • Health • kosu.org
CEO of FNB Honored for Business Excellence, Leadership

Vincent Delie, chairman, president and CEO of F.N.B. Corp. and its largest subsidiary, First National Bank, received two national awards.

businessjournaldaily.com logo
Jun 24 • 4:50 AM EDT • Business • businessjournaldaily.com
2026 NBA Draft Grades: Analysis for AJ Dybantsa, Darryn Peterson, Cameron Boozer, rest of first-round picks

Adam Finkelstein has the breakdown of each pick in one of the best drafts in recent memory

cbssports.com logo
Jun 24 • 12:12 AM EDT • Sports • cbssports.com
2026 NBA Draft grades, first-round pick-by-pick analysis: Wizards get A+ for selecting AJ Dybantsa No. 1
sports.yahoo.com logo
Jun 23 • 8:22 PM EDT • Sports • sports.yahoo.com
From martial law to democratic renewal in South Korea

An analysis of South Korea's democratic resilience following the December 2024 martial law crisis and its path toward democratic renewal.

brookings.edu logo
Jun 23 • 3:05 PM EDT • Politics • brookings.edu
Roku May Help Fox Avoid Aggregeddon

(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy

entertainment.substack.com logo
Jun 23 • 2:23 PM EDT • Entertainment • entertainment.substack.com
Alexi Lalas scolded by former USA teammate over ‘unwatchable’ Fox Sports punditry at World Cup

The Fox Sports pundit has attracted criticism for his views, while the chemistry with fellow analysts Thierry Henry, and Zlatan Ibrahimovic has left some viewers uncomfortable

sports.yahoo.com logo
Jun 23 • 2:17 PM EDT • Sports • sports.yahoo.com
Pre-RAMpocalypse Steam Machine Pricing was ~30% Cheaper

It's no secret that Valve's Steam Machine is launching at possibly the worst moment for both PC and console gaming hardware, given the ongoing DRAM crisis, but Valve engineer, Pierre-Loup Griffais, has recently shed light on the pre-RAM crisis pricing of the Steam Machine, revealing that it was neve...

techpowerup.com logo
Jun 23 • 2:06 PM EDT • Technology • techpowerup.com
Nvidia Unveils Science Reasoning AI Suite with BioNeMo Agent Toolkit

The toolkit has applications across generative chemistry, genomic analysis, protein design, and biomarker discovery.

genengnews.com logo
Jun 23 • 2:01 PM EDT • Science • genengnews.com
The New York Times Helped Turn Trans Rights Into Political Controversy, Analysis Finds

A new data investigation says the paper of record increasingly framed transgender rights as a debate instead of a lived reality.

them.us logo
Jun 23 • 1:26 PM EDT • Politics • them.us
BMO Lowers Expectations After Dave & Buster’s Entertainment, Inc. (PLAY)’s EBITDA Miss

Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) is among the best low priced stocks to get rich in 2026. Andrew Strelzik, an analyst at BMO Capital, trimmed the price target on Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) to $22 from $24 on June 16. As highlighted by the analyst, the company’s Q1 EBITDA missed consensus by […]

finance.yahoo.com logo
Jun 23 • 11:36 AM EDT • Entertainment • finance.yahoo.com
Leeds enhance data approach

Leeds United look will enhance their use of data intelligence in a bid to manage player welfare. The field of sporting analytics continues to grow and Leeds have deepened their links with Kitman Labs, who offer intelligence in bringing together data points to look after players from an injuries and developmental perspective. Kitman Labs have been working with Leeds for years at academy level but will now have a more joined up link with the club through to the first team.

sports.yahoo.com logo
Jun 23 • 11:16 AM EDT • Sports • sports.yahoo.com
Records: Rural Michigan ‘overlooked’ in Michigan’s $6B subsidy spending spree

A Bridge analysis finds that the northeast Lower Peninsula got $71 per person in economic development spending since 2022, compared to $854 in west Michigan. Some question the disparities.

bridgemi.com logo
Jun 23 • 11:00 AM EDT • Business • bridgemi.com
Apple's Foldable iPhone Could Lose Almost $1,300 in Value in First Year, Study Suggests

A new resale value study suggests that a $2,000 foldable iPhone could lose as much as $1,292 of its value within its first 12 months on the market, based on current foldable depreciation trends. The estimate comes from SellCell, which analyzed the 12-month resale performance of flagship smartphones from Apple, Samsung, Google, Motorola, and OnePlus.

macrumors.com logo
Jun 23 • 9:08 AM EDT • Technology • macrumors.com
"This is going to be a niche device" – Analysts react to the $1,000+ Steam Machine price reveal

Mat Piscatella, Joost van Dreunen, Manu Rosier, and Piers Harding-Rolls offer their thoughts on the price implications for Project Helix and PS6

gamesindustry.biz logo
Jun 23 • 7:01 AM EDT • Technology • gamesindustry.biz
Goldman Sachs analysts say EV adoption set to hammer demand for oil

Goldman Sachs says a shift spurred by the Iran War and its disruption to energy markets will put downward pressure on crude prices through 2027.

businessinsider.com logo
Jun 23 • 5:45 AM EDT • Business • businessinsider.com
Analysis | Mamdani views 2026 House endorsements as a 2028 test

The New York mayor wants to remake the Democratic Party.

washingtonpost.com logo
Jun 23 • 5:39 AM EDT • Politics • washingtonpost.com
Why prediction markets’ election picks are useful, even when they seem wrong

A Post analysis found that primary candidates ended up winning about as often as bettors thought they would.

washingtonpost.com logo
Jun 23 • 5:00 AM EDT • Politics • washingtonpost.com
Brexit Has Cost the UK Growth, Analysts Say, in the Decade Since the Vote

Citing lower trade and investment, analysts broadly agree that Britain’s economy is smaller than it would have been if the country had stayed in the E.U.

nytimes.com logo
Jun 23 • 12:00 AM EDT • Business • nytimes.com
Indian shares set to pause after oil-led rally

Indian shares were set to open flat on Tuesday, with analysts expecting a phase of consolidation in the absence of fresh triggers after gains in six out ​of seven sessions, while sentiment remained constructive on easing Middle East tensions.

reuters.com logo
Jun 22 • 10:33 PM EDT • Business • reuters.com
ANALYSIS: Fear not Britain, the EU doesn't agree on you rejoining either

Brussels heavyweights are clashing over whether Brexit can be reversed and on what terms

euractiv.com logo
Jun 22 • 10:00 PM EDT • Politics • euractiv.com
'The View' uses Barbara Walters in on-air ad urging viewers to push back against FCC: 'Use your voice'

'The View' used Barbara Walters in a new commercial urging audience action against the FCC amid legal drama: 'Use your voice,' an ABC spot advised.

ew.com logo
Jun 22 • 12:19 PM EDT • Entertainment • ew.com
Blending Creativity and Business with Emma Richey

Storytelling-based business owner Emma Richey chose to specialize in finance and securities analysis with the Oregon MBA to challenge herself analytically and pivot careers.

business.uoregon.edu logo
Jun 22 • 11:45 AM EDT • Business • business.uoregon.edu
Monday, June 22, 2026: The Club says this legacy tech stock's foundry business presents a major opportunity

Go behind the scenes with Jim Cramer and Jeff Marks of the CNBC Investing Club as they talk candidly about the market's biggest headlines, analyst calls and holdings in the Charitable Trust—and see up close how they decide when, and if, to take action on stocks.

cnbc.com logo
Jun 22 • 10:43 AM EDT • Business • cnbc.com
Health services M&A is active in 2026, but uncertainty slows volume: PwC

Buyers are being more selective amid heightened policy and reimbursement pressure in healthcare, according to the analysis. Still, deal value is up compared to the first half of 2025.

healthcaredive.com logo
Jun 22 • 8:35 AM EDT • Health • healthcaredive.com
Honorees brought science-based blood pressure care home to communities in need

Organizers of “Team Up to Take Down High Blood Pressure” in Philadelphia say collaboration has been crucial to the initiative’s success.

heart.org logo
Jun 22 • 8:00 AM EDT • Science • heart.org
GTA 6 'Vampire' Ferris Wheel Sparks Tech Expert Investigation

When Rockstar announced GTA 6 pre-orders would kick off on June 25, it did so with a short, looping video posted to the official website that offered a fresh look at Vice City. It’s meant to be viewed as you scroll down, a cool piece of GTA 6 media that sets the tone for your experience on the website. But this is GTA 6, and so everything is analyzed to within an inch of its life.

ign.com logo
Jun 22 • 7:40 AM EDT • Technology • ign.com
Science Over Tradition: Plymouth South Middle Schoolers Advocate for Later School Start Times

PLYMOUTH - June 15, 2026 - In a powerful demonstration of student advocacy, a delegation of eighth-grade students from Plymouth South Middle School presented compelling, science-based research to the School Committee, urging district leadership to push back school start times to improve adolescent mental health, well-being, and academic performance. The presentation sparked immediate commitment from the administration to formally evaluate the district’s schedule over the coming school year. Subscribe The Full Story The final in-person meeting of the academic year opened with a celebratory outdoor ceremony honoring dozens of elementary, middle, and high school student artists whose work was chosen for the biannual Central Office Artwork Awards. However, the evening’s primary policy focus quickly shifted to student-led civic action when eighth graders Sophia Scarini, Skye Togun, Leah Mansfield, James Moore, Avery Mahan and Lily Simpson took the podium. The students revealed that their presentation was the culmination of a year-long civics project involving local community assessments, interviews with former officials, and extensive literary analysis. The research sharply highlighted the biological mismatch between adolescent sleep patterns and current school schedules. Under the district’s current framework, Plymouth High Schools open at 7:20 a.m., Middle Schools at 8:12 a.m., and Elementary Schools at 9:05 a.m.. “The high school start times directly contradict students’ natural sleep patterns,” student Leah Mansfield explained, noting that the teenage brain does not naturally produce melatonin until around 11:00 p.m.. The student presentation underscored a harrowing correlation between sleep deprivation and severe mental health struggles, citing data that adolescents with insomnia are ten times more likely to develop depression. Conversely, data shows that just one additional hour of sleep results in a 28% reduction in students reporting feelings of depression or sadness.

southshore.news logo
Jun 22 • 7:03 AM EDT • Science • southshore.news
New York City and Lake Placid explore joint bid to host 2042 Winter Olympics and Paralympics

Committee established to look at feasibility of hosting Games after success of Milan Cortina event this year

nytimes.com logo
Jun 22 • 6:00 AM EDT • Sports • nytimes.com
Analysis | Republicans are meddling in Democratic primaries. Their record is mixed.

This practice is not entirely unusual as the midterms approach.

washingtonpost.com logo
Jun 22 • 5:48 AM EDT • Politics • washingtonpost.com
View: The rise of identity politics

Éric Zemmour’s diagnosis is not the standard analysis of why centrist leaders everywhere have grown so profoundly unpopular.

semafor.com logo
Jun 22 • 5:08 AM EDT • Politics • semafor.com
Howie Mandel: OCD like mine isn't a joke. It's paralyzing.

OCD became shorthand for being neat, organized or particular. Obsessive-compulsive disorder isn't about color-coding your closet. It's about control.

usatoday.com logo
Jun 22 • 5:03 AM EDT • Health • usatoday.com
Milan make decisions on new CEO and sporting director roles

Reports in Italy claim that Milan have finally come to a decision over their next permanent CEO and sporting director after going almost a full month without a senior management structure in place.Mil...

sports.yahoo.com logo
Jun 22 • 4:55 AM EDT • Sports • sports.yahoo.com
Apple's first Ultras are coming: 20 new products in 2026–2027 according to Bloomberg

Apple's new CEO John Ternus will begin his tenure in September with a wave of new products that will bring Apple fans many exciting new releases. Well-known Bloomberg analyst Mark Gurman has listed the most important new products coming our way after the summer break, including the first ones potentially bearing the “Ultra” moniker.

notebookcheck.net logo
Jun 22 • 1:56 AM EDT • Technology • notebookcheck.net
The Bucs unleashing Rueben Bain Jr. would help their defense

One analyst believes Tampa Bay's defense could benefit from allowing Rueben Bain Jr. to immediately play to his strengths.

sports.yahoo.com logo
Jun 21 • 10:06 PM EDT • Sports • sports.yahoo.com
Science-Backed Beauty Formulations Market Size and Growth Analysis Study 2026 to 2035

Global Science-Backed Beauty Formulations Market Size is predicted to grow at a 8.6% CAGR during the forecast period for 2026 to 2035. The skincare formulations segment is set to take a large share of the science-backed beauty market. This growth comes from more people focusing on skin health, anti-ageing, acne, hyperpigmentation, and barrier repair.

insightaceanalytic.com logo
Jun 21 • 8:00 PM EDT • Science • insightaceanalytic.com
The growing concentration of national influence in global science

Nature Human Behaviour - This analysis of nearly 240 million scientific papers reveals growing concentration of discursive influence in core, resource-wealthy countries, indicating that a few...

nature.com logo
Jun 21 • 8:00 PM EDT • Science • nature.com
The media has declared open season on Alexi Lalas

In the ever-growing genre of media criticism, few have ever been as soft a target as Fox Sports soccer analyst Alexi Lalas. It has seemingly become a once-every-four-years tradition. Fox will begin its World Cup coverage. Americans will rediscover everything they despise about the professional shit-stirrer. And a deluge of thinkpieces will follow, ripping the…

sports.yahoo.com logo
Jun 21 • 5:30 PM EDT • Sports • sports.yahoo.com
Belgium vs Iran Game Preview

Check out Zlatan Ibrahimović, Thierry Henry & Alexi Lalas pre-game analysis of Belgium vs Iran.

foxsports.com logo
Jun 21 • 2:33 PM EDT • Sports • foxsports.com
Prada serves up luxury fashion’s version of pasta pomodoro at Milan Fashion Week

Miuccia Prada and Raf Simons reimagine jeans-inspired basics in leather and technical fabrics for their latest collection.

seattletimes.com logo
Jun 21 • 12:43 PM EDT • Entertainment • seattletimes.com
Spain vs Saudi Arabia LIVE: World Cup 2026

Live updates as Spain face Saudi Arabia in Group H - follow the build-up, analysis and live text commentary of the game.

aljazeera.com logo
Jun 21 • 9:00 AM EDT • Sports • aljazeera.com
Wedbush Initiates Coverage on Flutter Entertainment (FLUT) Stock with Outperform Rating

Flutter Entertainment plc (NYSE:FLUT) is one of the Stocks with Potential to Explode in 2026. On June 17, Wedbush initiated coverage on the company’s stock with an “Outperform” rating and a price objective of $138.00. As per the analyst, the company is the world’s largest online sports betting and internet gaming operator and has exposure to the […]

finance.yahoo.com logo
Jun 21 • 7:19 AM EDT • Entertainment • finance.yahoo.com
Analyst Says Jaguars Should Extend Washington Before Season Starts

With Parker Washington poised for a massive breakout, Jacksonville must secure the rising star now before his market value skyrockets beyond the projected $20 million annual payday.

sports.yahoo.com logo
Jun 20 • 7:46 PM EDT • Sports • sports.yahoo.com
Deep dive
😐 Neutral (18%)
ahah
100%
Sandro Tonali transfer news: Tottenham's £80m bid rejected by Newcastle for Italy midfielder
skysports.com logo
Jun 20 • 5:00 PM EDT • Sports • skysports.com
☹️ Negative (-28%)
wow
100%
Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals

Cardinal Health (CAH) has drawn investor attention after its stock closed at $221.77. This has put recent performance and current valuation metrics in focus for those tracking large U.S. healthcare distributors. See our latest analysis for Cardinal Health. While Cardinal Health’s share price slipped around 2% in the latest session, the 30-day share price return of 10.55% and 1-year total shareholder return of 37.25% sit alongside a very large 5-year total shareholder return of 334.47%. Taken...

finance.yahoo.com logo
Jun 20 • 4:08 PM EDT • Health • finance.yahoo.com
Karl Rove analyzes political fallout from US-Iran deal, public opinion of the conflict

Fox News contributor Karl Rove joins ‘Fox News Live’ to discuss the political implications of the Iran memorandum of understanding (MOU) and the potential impact of U.S. public opinion of the deal.

foxnews.com logo
Jun 20 • 1:00 PM EDT • Politics • foxnews.com
Rockstar Releases New Official GTA 6 In-Game Screenshot

Rockstar Games releases a new official Grand Theft Auto 6 screenshot for fans to analyze and debate.

gamerant.com logo
Jun 20 • 12:44 PM EDT • Technology • gamerant.com
Trump deepens the dustup with Italy's Meloni, who says his 'unprovoked attacks are senseless'

President Donald Trump on Saturday lashed out at Italian Prime Minister Giorgia Meloni, insisting that she asked “over and over” for a photo with him at the recent Group of Seven summit and criticizing what he said was Italy’s lack of cooperation during the Iran war.

pbs.org logo
Jun 20 • 12:27 PM EDT • Politics • pbs.org
🙂 Positive (35%)
Trump says Meloni 'wants to be friends again' after Italy refused to help US amid Iran war

President Donald Trump said Giorgia Meloni did not let the U.S. use Italy's landing strips in its war against Iran and rejected being friends with her.

foxnews.com logo
Jun 20 • 11:23 AM EDT • Politics • foxnews.com
New research casts doubt on cannabis benefits, cites mental health risks

Fox News senior medical analyst Dr. Marc Siegel discusses new research on modern marijuana’s high THC potency and increased mental health risks on ‘Fox & Friends Weekend.’

foxnews.com logo
Jun 20 • 9:37 AM EDT • Health • foxnews.com
Trump deepens the dustup with Italy's Meloni over a disputed photo from the G7 summit

President Donald Trump is lashing out at Italian Prime Minister Giorgia Meloni once more

washingtonpost.com logo
Jun 20 • 9:12 AM EDT • Politics • washingtonpost.com
CBS Sports will need a new NFL booth

CBS Sports is heading into the 2026 NFL season with presumably two open slots in its fourth broadcast booth. ESPN re-signed Jason McCourty to a new multi-year exclusive deal on Thursday, pulling him away from the CBS booth he shared last season with play-by-play man Andrew Catalon, analyst Charles Davis, and sideline reporter A.J. Ross.…

sports.yahoo.com logo
Jun 20 • 9:00 AM EDT • Sports • sports.yahoo.com
Travel mistakes I made in Italy as a first-time tourist

I spent six days exploring three cities in Italy — Venice, Rome, and Milan. It was my first time visiting the country, and I left with regrets.

businessinsider.com logo
Jun 20 • 7:12 AM EDT • Business • businessinsider.com
🙂 Positive (50%)
Analysing the Trionda: The science behind the 2026 World Cup ball

How the history of soccer has been shaped by panels, grooves and a desire to avoid wobbliness

nytimes.com logo
Jun 20 • 12:10 AM EDT • Science • nytimes.com
😐 Neutral (13%)
wow
100%
Italian PM Meloni slams President Trump over photo claims: ‘Neither I nor Italy ever beg’
cnn.com logo
Jun 19 • 10:28 PM EDT • Politics • cnn.com
😐 Neutral (0%)
Trump and Italy's Giorgia Meloni used to be buds. But a rift is widening

"Italy and I do not beg," Meloni said in a video rebuke posted on social media Friday. Italy's top diplomat, meanwhile, said he was cancelling a visit to the U.S because of the alleged remarks.

npr.org logo
Jun 19 • 4:32 PM EDT • Politics • npr.org
High-Signal Publisher
Italy’s prime minister says Trump made up a story about her supposedly begging him for something. She wouldn’t be the first

After an Italian media outlet reported that President Donald Trump said Prime Minister Giorgia Meloni had “begged” him for a photo at the G7 summit this week, Meloni quickly posted a response on social media. Trump, she said, had “completely fabricated” the story, and she was “shocked.”

cnn.com logo
Jun 19 • 4:24 PM EDT • Politics • cnn.com
Deep dive
😐 Neutral (1%)
ahah
50%
wow
50%
AMC Entertainment Holdings (AMC) Stock Could Be 31% Overvalued After Attendance Rebound And $150 Million Raise

AMC Entertainment Holdings (AMC) is back in focus after it reported its strongest monthly attendance since 2019 in May and completed a US$150 million at-the-market equity offering to raise fresh capital. See our latest analysis for AMC Entertainment Holdings. These updates come during a sharp swing higher in AMC Entertainment Holdings' share price, with a 24.1% 7 day share price return and a 108.1% 30 day share price return, even as the 1 year total shareholder return is still down 6.3%...

finance.yahoo.com logo
Jun 19 • 4:10 PM EDT • Entertainment • finance.yahoo.com
Sphere Entertainment (SPHR) Stock Could Be 2% Undervalued After Immersive Content Momentum

Sphere Entertainment (SPHR) is back in focus after highlighting strong momentum in its immersive shows, including The Wizard of Oz at Sphere, and announcing a new Rocky Horror Picture Show experience, along with plans for additional global venues. See our latest analysis for Sphere Entertainment. That momentum is clearly reflected in Sphere Entertainment’s recent trading, with a 1-month share price return of 16.26% and a year to date share price return of 66.84%. The 1-year total shareholder...

simplywall.st logo
Jun 19 • 11:22 AM EDT • Entertainment • simplywall.st
Deep dive
😐 Neutral (20%)
love
57%
wow
43%
Italy's Meloni pushes back on Trump's 'fabricated' claim as top diplomat cancels U.S. trip

ROME (AP) — The Italian government closed ranks on Friday to slam U.S. President Donald Trump over his claim that Premier Giorgia Meloni had “begged” for a photo with him during the recent G7 summit, a pushback that suggested the longtime U.S. ally had had enough of Trump’s boasting. Italian Foreign Minister Antonio Tajani abruptly cancelled a planned trip to the United States this weekend, calling Trump’s claims “serious and offensive” toward Meloni and all

pbs.org logo
Jun 19 • 11:18 AM EDT • Politics • pbs.org
🙂 Positive (35%)
Roundup: Oil shock / AI receptionists / Warsh’s style

‘Baked-in’ damage: Even though the Strait of Hormuz has reopened in principle, analysts say the economic damage from the earlier disruption is already largely “baked in,” since supply chains, inventories and energy markets have already adjusted to shortages and higher costs. Oil prices have eased from their peak, but inflation pressures are expected to persist […]

businessreport.com logo
Jun 19 • 10:09 AM EDT • Business • businessreport.com